Prudential Financial Inc Angion Biomedica Corp. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.48 - $1.02 $8,544 - $18,156
-17,800 Reduced 51.74%
16,600 $9,000
Q3 2022

Nov 04, 2022
BUY
$0.94 - $1.23 $16,355 - $21,402
17,400 Added 102.35%
34,400 $32,000
Q2 2022

Aug 15, 2022
BUY
$1.1 - $2.23 $18,700 - $37,910
17,000 New
17,000 $19,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email